Katsuhiro Hamada

Title: Katsuhiro Hamada: Innovator in Anti-Ulcer Agents

Introduction

Katsuhiro Hamada is a notable inventor based in Nogi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Hamada's latest patents focus on urea derivatives that serve as effective anti-ulcer agents. The first patent describes urea derivatives characterized by a specific formula, where R₂ indicates a piperidino or pyrrolidino group, which may be substituted with a hydroxy group or a lower alkyl group having 1 to 13 carbon atoms. The formula also includes various alkyl and aromatic groups, making these compounds versatile in their application. The second patent similarly outlines anti-ulcer urea derivatives, emphasizing their potential as therapeutic agents.

Career Highlights

Katsuhiro Hamada is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments for ulcer-related conditions, showcasing his commitment to improving patient health.

Collaborations

Hamada has collaborated with esteemed colleagues such as Hiroshi Matsukubo and Toyomi Matsumoto. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Katsuhiro Hamada's contributions to the field of pharmaceuticals, particularly through his innovative anti-ulcer agents, highlight his role as a significant inventor. His work continues to impact the medical community positively.